002020 Income Statement - TTM - Zhejiang Jingxin Pharmaceutical Co., Ltd.

Income Statement (TTM)

Zhejiang Jingxin Pharmaceutical Co., Ltd. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2022 01-01	2022 03-31	2022 06-30	2022 09-30	2023 01-01	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31
Revenue	3,287	3,258	3,322	3,344	3,384	3,467	3,480	3,613	3,705	3,780	3,870	3,844	3,905	3,999	4,099	4,212	4,282	4,159	4,054
Change (%)		-0.88	1.96	0.68	1.20	2.43	0.38	3.82	2.55	2.03	2.38	-0.67	1.61	2.39	2.51	2.76	1.66	-2.88	-2.52
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	1,185	1,277	1,350	1,439	1,526	1,547	1,556	1,623	1,691	1,774	1,862	1,877	1,924	1,988	2,017	2,072	2,123	2,098	2,087
Change (%)		7.77	5.69	6.61	6.02	1.37	0.63	4.27	4.18	4.95	4.94	0.81	2.53	3.29	1.51	2.70	2.45	-1.19	-0.50
% of Revenue	36.05	39.20	40.63	43.03	45.08	44.61	44.73	44.92	45.63	46.94	48.11	48.83	49.27	49.70	49.22	49.19	49.57	50.44	51.48

Gross Operating Profit	2,102	1,981	1,972	1,905	1,859	1,920	1,923	1,990	2,014	2,006	2,008	1,967	1,981	2,011	2,082	2,140	2,159	2,061	1,967
Change (%)		-5.75	-0.45	-3.39	-2.44	3.30	0.17	3.46	1.21	-0.42	0.11	-2.05	0.73	1.53	3.49	2.82	0.89	-4.55	-4.57
% of Revenue	63.95	60.80	59.37	56.97	54.92	55.39	55.27	55.08	54.37	53.06	51.89	51.17	50.73	50.30	50.78	50.81	50.43	49.56	48.52

SG&A	1,461	1,176	1,128	1,039	949	982	963	1,002	1,008	989	971	933	937	1,001	1,023	1,036	1,054	930	869
Change (%)		-19.53	-4.10	-7.88	-8.59	3.38	-1.94	4.05	0.61	-1.90	-1.75	-3.97	0.50	6.83	2.13	1.34	1.66	-11.76	-6.48
% of Revenue	44.45	36.09	33.94	31.06	28.05	28.31	27.66	27.72	27.20	26.15	25.10	24.27	24.00	25.04	24.95	24.60	24.60	22.35	21.44

R&D	215	258	270	278	303	334	335	347	353	367	369	368	380	401	418	427	411	383	372
Change (%)		19.96	4.73	2.78	9.01	10.42	0.24	3.62	1.61	4.08	0.44	-0.17	3.27	5.45	4.38	2.00	-3.73	-6.68	-2.88
% of Revenue	6.54	7.92	8.13	8.30	8.94	9.64	9.63	9.61	9.52	9.71	9.53	9.58	9.73	10.02	10.21	10.13	9.59	9.22	9.18

OpEx	2,891	2,739	2,783	2,781	2,808	2,889	2,891	3,015	3,089	3,166	3,231	3,212	3,309	3,420	3,486	3,572	3,606	3,444	3,377
Change (%)		-5.26	1.62	-0.09	0.97	2.89	0.06	4.30	2.47	2.48	2.05	-0.59	3.03	3.34	1.95	2.45	0.96	-4.50	-1.94
% of Revenue	87.95	84.06	83.78	83.15	82.96	83.33	83.07	83.45	83.40	83.76	83.49	83.57	84.74	85.52	85.05	84.80	84.22	82.82	83.31

Operating Income	396	519	539	564	577	578	589	598	615	614	639	632	596	579	613	640	676	715	677
Change (%)		31.15	3.72	4.62	2.34	0.19	1.94	1.48	2.91	-0.21	4.06	-1.11	-5.65	-2.83	5.82	4.51	5.53	5.73	-5.31
% of Revenue	12.05	15.94	16.22	16.85	17.04	16.67	16.93	16.55	16.60	16.24	16.51	16.43	15.26	14.48	14.95	15.20	15.78	17.18	16.69

Interest Expense	-15	-6	-6	-10	-1	-5	-5	-5	-10	-6	-8	-6	-7	-7	-9	-9	-8	-8	-6
Change (%)		-61.11	-0.00	70.02	-88.32	317.77	-0.00	3.69	99.94	-41.66	37.46	-28.17	16.46	5.76	20.29	1.39	-6.57	-7.10	-26.01
% of Revenue	-0.47	-0.18	-0.18	-0.30	-0.04	-0.14	-0.14	-0.14	-0.28	-0.16	-0.21	-0.15	-0.18	-0.18	-0.21	-0.21	-0.19	-0.19	-0.14

Net Income	404	653	691	708	720	613	616	630	645	662	676	681	663	619	639	705	721	712	704
Change (%)		61.66	5.87	2.38	1.65	-14.87	0.53	2.28	2.44	2.64	2.10	0.73	-2.64	-6.67	3.23	10.36	2.30	-1.29	-1.11
% of Revenue	12.29	20.04	20.81	21.17	21.26	17.67	17.70	17.43	17.42	17.52	17.47	17.72	16.98	15.48	15.59	16.74	16.84	17.12	17.37

Source: Capital IQ

Zhejiang Jingxin Pharmaceutical Co., Ltd. - Income Statement (TTM)

Income Statement (TTM)